Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Mar. 31, 2025	Jun. 30, 2024
Current assets:
Cash and cash equivalents		$ 77,824	$ 68,570
Restricted cash		1,013	485
Accounts receivable, net of allowance for credit losses of $545 and $2,251 as of March 31, 2025, and June 30, 2024, respectively	[1]	78,191	92,001
Inventories, net		146,445	138,324
Prepaid expenses and other current assets	[2]	29,203	23,006
Deferred cost of revenue		782	850
Total current assets		333,458	323,236
Property and equipment, net		27,081	24,774
Investment in joint venture		9,284	9,826
Operating lease right-of-use assets, net		34,023	33,773
Goodwill		57,720	57,672
Restricted cash		1,407	1,337
Other assets		21,318	18,009
Total assets		484,291	468,627
Current liabilities:
Accounts payable		46,319	50,020
Accrued compensation		13,413	17,128
Operating lease liabilities, current		7,233	6,218
Other accrued liabilities		34,943	28,508
Customer advances		12,194	13,988
Deferred revenue		81,753	71,649
Short-term debt		7,574	7,756
Total current liabilities		203,429	195,267
Long-term liabilities:
Operating lease liabilities, non-current		33,352	32,373
Long-term other liabilities		6,127	7,389
Deferred revenue, non-current		25,591	24,114
Long-term debt		166,209	164,400
Total liabilities		434,708	423,543
Commitments and contingencies (Note 7)
Stockholders' equity:
Common stock, $0.001 par value; authorized: 200,000,000 shares as of March 31, 2025, and June 30, 2024, respectively; issued and outstanding: 102,850,591 and 100,194,932 shares at March 31, 2025, and June 30, 2024, respectively		103	100
Additional paid-in-capital		575,032	566,887
Accumulated other comprehensive loss		(5,157)	(4,222)
Accumulated deficit		(520,395)	(517,681)
Total stockholders' equity		49,583	45,084
Total liabilities and stockholders' equity		$ 484,291	$ 468,627

[1] Includes accounts receivable from the joint venture, an equity method investment, of $19,352 and $25,339 as of March 31, 2025, and June 30, 2024, respectively. See Note 12.

[2] Includes other receivables from the joint venture, an equity method investment, of $373 and $743 as of March 31, 2025, and June 30, 2024, respectively.